As a first-time investor, it can be daunting trying to figure out where to put your money. But don’t worry, we’ve got you covered. Join us as we cover different types of investments!

What are the most popular types of investments? | Get Rich Slow Club

Whilst none of us are the next Warren Buffett, we have the ability to "own a piece of America", as he often suggests. For this reason, we're sharing the 10 most most popular US stocks on Pearler. 

Check out Pearler's most popular US stocks

Think of community data as a compass: you can choose any stock you want, but our community keeps pointing in the same general direction - simple, diversified, and cheap ETFs. Let's take a look at the 10 most popular ETFs on Pearler.

These are Pearler's most popular ETFs

Aclaris Therapeutics Inc (ACRS:US) Share Price | Pearler

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

The iShares S&P 500 ETF seeks to track the investment results of an index composed of large-capitalisation U.S. equities.

iShares S&P 500 Etf

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

Vanguard Australian Shares Index ETF (ASX: VAS) seeks to track the performance of the ASX 300 index before account fees, expenses, and taxes. The index tracks the top 300 companies on the Australian Securities Exchange (ASX). These are mostly large and established Australian companies. It is a popular choice among passive individual investors who don't have the time or the expertise to actively invest in stocks.

Vanguard Australian Shares Index Etf

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in developing precision oncology medicines. The Company uses its precision medicine platform, Acrivon Predictive Precision Proteomics (AP3), to develop its pipeline of oncology drug candidates. Its lead clinical candidate, ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 with sub single-digit nM and single-digit nM potency. ACR-368 is in Phase II trial across multiple solid tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. Using its AP3 platform, it has developed a predictive OncoSignature test for ACR-368, called ACR-368 OncoSignature, that can predict patient response to ACR-368 monotherapy, which improves the clinical overall response rate (ORR), and has the potential to enable expedited drug development. The Company is also developing two preclinical drug programs, such as WEE1 inhibitors and PKMYT1 inhibitor.

ACRIVON THERAPEUTICS, INC.

Acropolis Infrastructure Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search for a business combination target in infrastructure, infrastructure services and related sectors in North America. It has no operations and has generated no revenues.

ACROPOLIS INFRASTRUCTURE - A

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a pipeline of drug candidates to address the needs of patients with immuno-inflammatory diseases. The Company has a multi-stage portfolio of drug candidates powered by a robust research and development (R&D) engine exploring protein kinase regulation. The Company operates through two segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The contract research segment includes provision of laboratory services. The Company is also engaged in identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize its novel drug candidates.

Aclaris Therapeutics Inc

Desktop Metal, Inc. offers additive manufacturing technologies focused on the production of end-use parts. The Company offers a portfolio of integrated additive manufacturing solutions comprised of hardware, software, materials and services with support for metals, polymers, elastomers, ceramics, sands, composites, wood and biocompatible materials. The Company’s product platforms include metal additive manufacturing systems, include production system, shop system platform, X-series platform and studio system platform; photopolymer additive manufacturing systems, which includes Xtreme 8K platform, Einstein series, P4K platform, envision one platform and D4K pro platform; digital casting additive manufacturing systems, which includes S-Max platform, robotic additive manufacturing (RAM) platform and S-Print; composite additive manufacturing systems, which includes fiber platform, and bio fabrication additive manufacturing systems which includes three-dimensional (3D)-bio plotter platform.

Desktop Metal, Inc.

Dynatrace, Inc. offers a unified observability and security platform with analytics and automation for dynamic, hybrid, multi-cloud environments. The Company’s Dynatrace Software Intelligence Platform provides application and micro service monitoring (APM), runtime application security, infrastructure monitoring, digital experience monitoring (DEM), business analytics, and cloud automation. Its product offerings include Applications and Microservices Monitoring, Infrastructure Monitoring, Application Security, Log Management and Analytics, Digital Experience Monitoring, Digital Business Analytics, and Cloud Automation. Its Dynatrace Infrastructure Monitoring provides complete visibility into a customer’s infrastructure layer across public and private clouds and hybrid, multi-cloud environments. It also provides real-time detection and blocking to help protect against injection attacks that exploit critical vulnerabilities, such as Log4Shell.

Dynatrace Inc

Eaton Corporation plc is a power management company. The Company's Electrical Americas segment consists of electrical components, industrial components, power distribution and assemblies, residential products, single phase power quality and connectivity, three phase power quality, and wiring devices, among others. The Electrical Global segment consists of electrical components, industrial components, power distribution and assemblies, single phase and three phase power quality, and services. The Vehicle segment is engaged in the design, manufacture, marketing, and supply of drivetrain, powertrain systems and critical components for cars, light trucks, and commercial vehicles. The Aerospace segment is a supplier of aerospace fuel, hydraulics, and pneumatic systems for commercial and military use, as well as filtration systems for industrial applications. The eMobility segment designs, manufactures, markets, and supplies, mechanical, electrical, and electronic components and systems.

Eaton Corporation plc

Ecolab Inc. provides water, hygiene and infection prevention solutions and services. The Company delivers various solutions, data-driven insights and personalized service to various industries. Its segments include Global Industrial, Global Institutional & Specialty and Global Healthcare & Life Sciences. Its Global Industrial segment provides water treatment and process applications, and cleaning and sanitizing solutions, primarily to industrial customers within the manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. Its Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government, education and retail industries. Its Global Healthcare & Life Sciences segment provides specialized cleaning and sanitizing products to the healthcare, personal care and pharmaceutical industries.

Ecolab Inc.

Diamondback Energy, Inc. is an independent oil and gas company, which is focused on the acquisition, development, exploration and exploitation of unconventional, onshore oil and natural gas reserves in the Permian Basin in West Texas. The Company operates through upstream segment, which is engaged in the acquisition, development, exploration and exploitation of unconventional, onshore oil and natural gas reserves primarily in the Permian Basin in West Texas. The midstream operations are focused on owning, operating, developing and acquiring midstream infrastructure assets in the Midland and Delaware Basins of the Permian Basin. Its total acreage position in the Permian Basin is approximately 508,767 net acres, which consisted primarily of approximately 325,540 acres in the Midland Basin and approximately 150,719 acres in the Delaware Basin. The Company’s subsidiaries include Diamondback E&P LLC, Viper Energy Partners GP LLC, Rattler Midstream GP LLC, and QEP Resources, Inc.

ACRS

Buy

👑 Overview

📈

N/A

Annual Growth

🌏

0

Pearlers Invested

Key information

🔎 Fund Overview

Price History*

Unsure how much or often to invest?

🗓️ Investing frequency calculator

💵 Investing amount calculator

⏱️ Investing duration calculator

💵

6.50 AUD*

Purchase Fee

💼

N/A

Management Fee

💸

Want to know the long term costs?

Calculate the historic long term costs to hold your investments

Technical Info

$8.29

How our community is investing

0

N/A

N/A

N/A

N/A

ACRS investor breakdown

💵 Income of investors

👶 Age of investors

🙋 Legal gender of investors

$1.75 USD

Find Out More

$49.70 USD

Find Out More

$182.46 USD

Find Out More

$166.91 USD

Find Out More

$130.99 USD

Find Out More

$12.55 USD

Find Out More

$10.23 USD

Find Out More

Buy